Cargando…

Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization

Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally...

Descripción completa

Detalles Bibliográficos
Autores principales: Konczalik, Wojciech, Acher, Peter, Tam, Matthew, Lodge, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243295/
https://www.ncbi.nlm.nih.gov/pubmed/30460001
http://dx.doi.org/10.1259/bjrcr.20150031
_version_ 1783371949602242560
author Konczalik, Wojciech
Acher, Peter
Tam, Matthew
Lodge, Richard
author_facet Konczalik, Wojciech
Acher, Peter
Tam, Matthew
Lodge, Richard
author_sort Konczalik, Wojciech
collection PubMed
description Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally advanced prostatic adenocarcinoma and prior history of prostate brachytherapy, androgen deprivation therapy and chemotherapy presented with persistent haematuria that did not respond to endourological intervention. He was successfully treated with selective embolization of the vesical and prostatic vessels under fluoroscopic guidance. Angiographic embolization represents a safe and effective means of achieving haemostasis in patients not fit for surgerywho would otherwise be resigned to terminal care treatment.
format Online
Article
Text
id pubmed-6243295
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The British Institute of Radiology
record_format MEDLINE/PubMed
spelling pubmed-62432952018-11-20 Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization Konczalik, Wojciech Acher, Peter Tam, Matthew Lodge, Richard BJR Case Rep Case Report Haematuria is a known complication of prostatic malignancy and in severe cases can be unresponsive to bladder irrigation and endoscopic interventions. This report describes selective angiographic embolization as a means of haemorrhage control in adenocarcinoma of the prostate. A patient with locally advanced prostatic adenocarcinoma and prior history of prostate brachytherapy, androgen deprivation therapy and chemotherapy presented with persistent haematuria that did not respond to endourological intervention. He was successfully treated with selective embolization of the vesical and prostatic vessels under fluoroscopic guidance. Angiographic embolization represents a safe and effective means of achieving haemostasis in patients not fit for surgerywho would otherwise be resigned to terminal care treatment. The British Institute of Radiology 2016-11-02 /pmc/articles/PMC6243295/ /pubmed/30460001 http://dx.doi.org/10.1259/bjrcr.20150031 Text en © 2016 The Authors. Published by the British Institute of Radiology http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Konczalik, Wojciech
Acher, Peter
Tam, Matthew
Lodge, Richard
Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title_full Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title_fullStr Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title_full_unstemmed Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title_short Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
title_sort management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243295/
https://www.ncbi.nlm.nih.gov/pubmed/30460001
http://dx.doi.org/10.1259/bjrcr.20150031
work_keys_str_mv AT konczalikwojciech managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization
AT acherpeter managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization
AT tammatthew managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization
AT lodgerichard managementofrefractoryhaematuriafollowingradiationtherapyandrecurrentadenocarcinomaoftheprostatewithfluoroscopicguidedselectivepelvicembolization